DrugPatentWatch Database Preview
Profile for Austria Patent: 496062
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Austria Patent: 496062
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Apr 14, 2025 | Onyx Therap | KYPROLIS | carfilzomib |
Start Trial | Jul 20, 2026 | Onyx Therap | KYPROLIS | carfilzomib |
Start Trial | Apr 14, 2025 | Onyx Therap | KYPROLIS | carfilzomib |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |